The Nature of COVID-19: Impact and Recovery in US Hospitals
By Monish Rajpal, Jonas Funk and Ilya Trakhtenberg of L.E.K. Consulting In light of COVID-19, L.E.K. Consulting has
EY + AdvaMed MedTech CEO Roundtables
By Jim Welch, EY Global MedTech Leader, Health Sciences and Wellness On August 26, 2020, AdvaMed and EY
It’s Not About the Robot: Fully Realizing the Benefits of Digital Surgery
By Brian Chapman, Principal and Leader of ZS’s Medtech PracticeBrian Chapman is a principal in ZS’s Evanston office
RWD for Evaluating Device & Diagnostic Performance & Outcomes
by Richard Gliklich, MD, CEO of OM1 and Michelle Leavy, MPH, Head of Health Policy at OM1 Interest
How Medtech and Digital Therapeutics Are Changing the Outcomes Power Paradigm
By Susan Garfield, Principal at EY Due to COVID-19, stakeholders across the health care and life sciences industry
The acceleration of digital healthcare innovation as the legacy of the global COVID pandemic
By The UK’s Department for International Trade “In normal times, innovation is a very slow and ponderous process,
Innovation must continue during the time of COVID-19
By Peter Shen, Global Head of Research & Development, Medical Devices, Johnson & Johnson While it’s true that
People Are Worried About Their Health, But They’re Not Going to the Doctor
By Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices Living through a pandemic has put the importance
The medtech mulligan: Why COVID-19 is a reinvention opportunity
By Brian Chapman, Principal and Leader of ZS’s Medtech PracticeBrian Chapman is a principal in ZS’s Evanston office
Zooming in on Quebec’s thriving MedTech industry
by The Coolest Hotspot, Quebec Life Sciences and Health Tech Hub The Quebec medical technology industry has been